Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAM for menopause

This article was originally published in The Tan Sheet

Executive Summary

Previous use of complementary and alternative medicine therapies is "most consistent predictor of subsequent use" of CAM during menopause, according to NCCAM-sponsored study published in November American Journal of Public Health. Researchers Yali Bair, UC-Davis, et al., expected to find CAM use would be catalyzed by physical, mental symptoms commonly associated with menopause. However, results indicated "women were already using these therapies and...at the point in midlife at which they were surveyed, symptom relief was not a primary reason for CAM use." Almost half of study participants used at least one CAM therapy during the first year of study...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel